Prof. Armin Gerger provides a review of the BEACON Study.
Prof. Armin Gerger provides a review of the BEACON Study.
Since 2012 Dr Armin Gerger is professor at the Medial University in Graz, Austria. He works as a clinical oncologist and coordinates the Subcentre for Gastrointestinal Neoplasia at the Comprehensive Cancer Centre, Graz. He leads the Pharmacogenetics Research Unit, at the Division of Clinical Oncology of the Medical University of Graz, and the Area “Cancer” of the Centre for Biomarker Research in Medicine (CBmed). Dr Gerger’s research focuses on prognostic and predictive genetic biomarkers in gastrointestinal cancer, which he developed further as a research fellow at the Norris Comprehensive Cancer Centre of the University of Southern California. Dr Gerger’s research activity is mirrored in several papers in high-ranked scientific journals and significant extramural funding.
Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series
An interactive patient case video series from breast cancer specialists
How will the latest data impact clinical practice?
An expert panel discussion hosted by eChinaHealth and COR2ED
How will the latest data impact clinical practice?